.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cerilliant
Chubb
Accenture
Novartis
Daiichi Sankyo
US Department of Justice
Express Scripts
Chinese Patent Office
Cantor Fitzgerald

Generated: November 20, 2017

DrugPatentWatch Database Preview

Us Pharm Holdings Company Profile

« Back to Dashboard

What is the competitive landscape for US PHARM HOLDINGS, and what generic and branded alternatives to US PHARM HOLDINGS drugs are available?

US PHARM HOLDINGS has ten approved drugs.



Summary for Us Pharm Holdings

US Patents:0
Tradenames:10
Ingredients:8
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharm Holdings
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
cefotaxime sodium
INJECTABLE;INJECTION050596-002May 20, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cefotaxime sodium
INJECTABLE;INJECTION050596-001May 20, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
SYRUP;ORAL005010-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
HIPREX
methenamine hippurate
TABLET;ORAL017681-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
CLAFORAN
cefotaxime sodium
INJECTABLE;INJECTION050547-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION005010-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
NORPRAMIN
desipramine hydrochloride
TABLET;ORAL014399-006Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
CLAFORAN
cefotaxime sodium
INJECTABLE;INJECTION050547-004Dec 29, 1983APRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
CLAFORAN
cefotaxime sodium
INJECTABLE;INJECTION050547-003Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Us Pharm Holdings

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings
NORPRAMIN
desipramine hydrochloride
TABLET;ORAL014399-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
NORPRAMIN
desipramine hydrochloride
TABLET;ORAL014399-007Feb 11, 1982► Subscribe► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
ANZEMET
dolasetron mesylate
TABLET;ORAL020623-001Sep 11, 1997► Subscribe► Subscribe
Us Pharm Holdings
NORPRAMIN
desipramine hydrochloride
TABLET;ORAL014399-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
ANZEMET
dolasetron mesylate
INJECTABLE;INJECTION020624-002Sep 11, 1997► Subscribe► Subscribe
Us Pharm Holdings
ANZEMET
dolasetron mesylate
INJECTABLE;INJECTION020624-001Sep 11, 1997► Subscribe► Subscribe
Us Pharm Holdings
NORPRAMIN
desipramine hydrochloride
TABLET;ORAL014399-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
NORPRAMIN
desipramine hydrochloride
TABLET;ORAL014399-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm Holdings
TRENTAL
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL018631-001Aug 30, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Merck
Baxter
Cerilliant
McKinsey
Moodys
Federal Trade Commission
AstraZeneca
Fish and Richardson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot